Vanda Pharmaceuticals (VNDA) Cash from Investing Activities Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -114.28% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 826.39% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -674.01% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -166.24% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -122.45% |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | -53.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53.91% |
| Dec 31, 2025 | 1,023.62% |
| Sep 30, 2025 | 77.18% |
| Jun 30, 2025 | -0.05% |
| Mar 31, 2025 | 340.98% |
| Dec 31, 2024 | 109.12% |
| Sep 30, 2024 | -65.87% |
| Jun 30, 2024 | 92.00% |
| Mar 31, 2024 | -109.73% |
| Dec 31, 2023 | -158.05% |
| Sep 30, 2023 | 262.22% |
| Jun 30, 2023 | -1,208.21% |
| Mar 31, 2023 | 1,623.67% |
| Dec 31, 2022 | 390.13% |
| Sep 30, 2022 | -31.28% |
| Jun 30, 2022 | 57.31% |
| Mar 31, 2022 | 15,204.23% |
| Dec 31, 2021 | -55.81% |
| Sep 30, 2021 | 65.33% |
| Jun 30, 2021 | -1,351.13% |
| Mar 31, 2021 | -99.65% |
| Dec 31, 2020 | -167.83% |
| Sep 30, 2020 | -244.85% |
| Jun 30, 2020 | 123.24% |
| Mar 31, 2020 | 155.69% |
| Dec 31, 2019 | 60.58% |
| Sep 30, 2019 | -55.80% |
| Jun 30, 2019 | 88.39% |
| Mar 31, 2019 | -323.46% |
| Dec 31, 2018 | -314.70% |
| Sep 30, 2018 | -264.79% |
| Jun 30, 2018 | -1,637.53% |
| Mar 31, 2018 | 195.01% |
| Dec 31, 2017 | -9.50% |
| Sep 30, 2017 | 128.21% |
| Jun 30, 2017 | 56.18% |
| Mar 31, 2017 | -137.52% |
| Dec 31, 2016 | 84.28% |
| Sep 30, 2016 | 948.75% |
| Jun 30, 2016 | -569.10% |
| Mar 31, 2016 | 78.47% |
| Dec 31, 2015 | 115.48% |
| Sep 30, 2015 | -104.88% |
| Jun 30, 2015 | -72.65% |
| Mar 31, 2015 | -8,729.31% |
| Dec 31, 2014 | 56.61% |
| Sep 30, 2014 | 81,742.86% |
| Jun 30, 2014 | 990.12% |
| Mar 31, 2014 | -98.72% |
| Dec 31, 2013 | -3,346.80% |
| Sep 30, 2013 | -100.03% |
| Jun 30, 2013 | 163.74% |
| Mar 31, 2013 | 5.60% |
| Dec 31, 2012 | -104.77% |
| Sep 30, 2012 | 18.63% |
| Jun 30, 2012 | -142.81% |
| Mar 31, 2012 | 118.23% |
| Dec 31, 2011 | 171.11% |
| Sep 30, 2011 | 144.83% |